Why Merck Crushed the Market Today
Merck (NYSE: MRK) stock was the very picture of health on Thursday. The big pharmaceutical company's stock posted a nearly 5% gain on price, thanks to a first-quarter earnings report that was well-received by investors.
Merck revealed that it took in $15.9 billion in sales for the period, a robust 50% higher on a year-over-year basis. Non-GAAP (adjusted) net income swelled even more, rising 84% to over $5.4 billion, or $2.14 per share.
Image source: Getty Images.
Source Fool.com
